All In MedTech

Device Trial Radar · NCT03716934

CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 196 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

196

Actual

Start

Jun 27, 2018

Primary completion

Apr 18, 2022

Study completion Apr 18, 2022

Sponsor

Lead sponsor
Hospital San Carlos, MadridAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 23, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, randomized, multicenter study comparing the relative efficacy and safety of cryoablation of PVs using the Arctic Front Advance® balloon catheter with antiarrhythmic therapy in patients with persistent AF.

Conditions

  • Atrial Fibrillation

Interventions

  • Arctic Front Advance® balloon catheterDevice

    Cryoablation of bidirectional block of all pulmonary veins

  • Antiarrhythmic drugDrug

    The drug will be chosen based on the preference of the researcher / responsible physician and current clinical practice guidelines.

  • Confirm RX heart monitor® (Abbott)Device

    Is a subcutaneous implantable device that provides continuous monitoring of the heart rate for more than 3 years without any effect on cardiac function

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival time with atrial fibrilation, auricular flutter or tachycardiaTime frame: Up to 9 months.
  2. Presence of death or one major complications.Time frame: first month
  3. Presence of death or one major complications.Time frame: fourth month

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fundacion para Investigación Biomedica Hospital Clinico San Carlos

    Madrid, Madrid, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.